141 related articles for article (PubMed ID: 37975600)
1. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
Chandar AK; Keerthy K; Gupta R; Grady WM; Canto MI; Shaheen NJ; Thota PN; Iyer PG; Wang JS; Falk GW; Abrams JA; Dumot J; Faulx A; Markowitz SD; Willis J; Moinova H; Guda K; Brock W; Chak A
Am J Gastroenterol; 2024 May; 119(5):823-829. PubMed ID: 37975600
[TBL] [Abstract][Full Text] [Related]
2. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
3. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
4. Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett's Esophagus, and Barrett's Esophagus-Related Neoplasia in the United States.
Sharma P; Falk GW; Bhor M; Ozbay AB; Latremouille-Viau D; Guerin A; Shi S; Elvekrog MM; Limburg P
J Health Econ Outcomes Res; 2023; 10(1):51-58. PubMed ID: 36883055
[No Abstract] [Full Text] [Related]
5. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.
Rubenstein JH; Scheiman JM; Sadeghi S; Whiteman D; Inadomi JM
Am J Gastroenterol; 2011 Feb; 106(2):254-60. PubMed ID: 21139576
[TBL] [Abstract][Full Text] [Related]
6. Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.
Holmberg D; Ness-Jensen E; Mattsson F; Lagergren J
Int J Cancer; 2020 Jul; 147(1):93-99. PubMed ID: 31583704
[TBL] [Abstract][Full Text] [Related]
7. Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease.
Postma GN; Tomek MS; Belafsky PC; Koufman JA
Ann Otol Rhinol Laryngol; 2001 Dec; 110(12):1114-6. PubMed ID: 11768699
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk.
Cheung WY; Zhai R; Kulke MH; Heist RS; Asomaning K; Ma C; Wang Z; Su L; Lanuti M; Tanabe KK; Christiani DC; Liu G
Carcinogenesis; 2009 Aug; 30(8):1363-7. PubMed ID: 19520791
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Barrett's Esophagus and Esophageal Adenocarcinoma With and Without Gastroesophageal Reflux: A Systematic Review and Meta-analysis.
Saha B; Vantanasiri K; Mohan BP; Goyal R; Garg N; Gerberi D; Kisiel JB; Singh S; Iyer PG
Clin Gastroenterol Hepatol; 2023 Oct; ():. PubMed ID: 37879525
[TBL] [Abstract][Full Text] [Related]
10. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma.
Cheung WY; Zhai R; Bradbury P; Hopkins J; Kulke MH; Heist RS; Asomaning K; Ma C; Xu W; Wang Z; Hooshmand S; Su L; Christiani DC; Liu G
Int J Cancer; 2012 Dec; 131(11):2478-86. PubMed ID: 22422400
[TBL] [Abstract][Full Text] [Related]
12. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.
Hammad TA; Thrift AP; El-Serag HB; Husain NS
Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493
[TBL] [Abstract][Full Text] [Related]
13. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
[TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma.
Lagergren J; Mattsson F; Nyrén O
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):45-51. PubMed ID: 23920035
[TBL] [Abstract][Full Text] [Related]
15. The Y-chromosome F haplogroup contributes to the development of Barrett's esophagus-associated esophageal adenocarcinoma in a white male population.
Westra WM; Rygiel AM; Mostafavi N; de Wit GMJ; Roes AL; Moons LMG; Peppelenbosch MP; Ouburg S; Morré SA; Jacobs M; Siersema PD; Repping S; Wang KK; Krishnadath KK
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32129453
[TBL] [Abstract][Full Text] [Related]
16. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
17. Significant decline in the prevalence of Barrett's esophagus among patients with gastroesophageal reflux disease.
Hamade N; Weng G; Desai M; Chandrasekar VT; Dasari C; Kennedy K; Sharma P
Dis Esophagus; 2021 May; 34(5):. PubMed ID: 33458760
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in oesophageal diseases.
Al Dulaimi D
Gastroenterol Hepatol Bed Bench; 2014; 7(3):186-9. PubMed ID: 25120902
[TBL] [Abstract][Full Text] [Related]
19. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma.
Sawas T; Zamani SA; Killcoyne S; Dullea A; Wang KK; Iyer PG; Fitzgerald RC; Katzka DA
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1709-1718. PubMed ID: 34757196
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal Reflux Disease Is Not a Great Screening Criterion: Time to Move on to Other Strategies for Controlling the Burden of Esophageal Adenocarcinoma.
Rubenstein JH
Am J Gastroenterol; 2022 Nov; 117(11):1759-1761. PubMed ID: 36327434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
